EUCTR2006-000485-36-GB进行中（未招募）不适用
A randomised, double blind, placebo controlled study to Assess The Effect of Antibiotic Therapy on Chronic Rejection in Human Lung Transplantation - Azithromycin Study
ewcastle upon Tyne Hospitals NHS Trust0 个研究点目标入组 64 人开始时间: 2006年9月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Lung transplant recipient
- •2. Male or Female
- •3. Age 16 years or over
- •4. Airflow limitation – FEV1 < 80% maximum recorded post transplant
- •5. Ability to give Informed Consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Airflow limitation caused by other clinical problems (e.g clinical infection)
- •2. Known hypersensitivity to Azithromycin or any of the macrolide antibiotics
- •3. Participation in another drug related trial within 90days
- •4. Severe renal or hepatic impairment
- •5. Use of concomitant medication that would interact with azithromycin
研究者
相似试验
进行中（未招募）
1 期
A randomised, double blind, placebo controlled study to assess the effect of testosterone treatment on arterial stiffness in patients with type 2 diabetes, peripheral vascular disease and hypogonadism. - Testosterone Replacement in Diabetes and Vascular DiseaseMale HypogonadismEUCTR2005-003652-35-GBBarnsley Hospital NHS Foundation Trust30
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to assess the safety and the efficacy of neridronate 100 mg - 4 i.v. infusions in a course of 10 days treatment - in patients with algodystrophic syndrome. - NDEUCTR2007-003372-18-ITABIOGEN PHARMA
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to evaluate the pharmacodynamics, safety, tolerability and pharmacokinetics profile of SLx-4090 over 14 days dosing in subjects with high triglyceride values.Dyslipidemia/hypertriglyceridemiaMedDRA version: 8.1Level: LLTClassification code 10058110Term: DyslipidemiaEUCTR2007-000536-95-DESurface Logix
进行中（未招募）
1 期
A randomised, double-blind, placebo controlled study of AIMSPRO in Multiple Sclerosis - AIMSPRO in MS bladder functioOveractive Bladder in Secondary Progressive Multiple Sclerosis and the other neurological symptoms associated with Secondary Progressive Multiple SclerosisMedDRA version: 9.1 Level: LLT Classification code 10063400 Term: Secondary progressive multiple sclerosisMedDRA version: 9.1 Level: LLT Classification code 10059617 Term: Overactive bladderMedDRA version: 9.1 Level: LLT Classification code 10012547 Term: Detrusor hyperreflexiaEUCTR2006-006872-39-GBDaval International Limited20
尚未招募
1 期
INNA-051 dry powder safety and tolerability studyRespiratory infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12624000635561ENA Respiratory Pty Ltd40